(AGENPARL) - Roma, 29 Ottobre 2024 - (AGENPARL) – mar 29 ottobre 2024 8.00 AM CET / 29-Oct-2024 / Detection Technology Oyj (FNFI:DETEC)
Detection Technology Plc company announcement 29 October 2024 at 09:00 (EET)
DETECTION TECHNOLOGY PLC BUSINESS REVIEW JANUARY-SEPTEMBER 2024
Detection Technology Q3 2024: Improved result and double-digit growth
July-September 2024 highlights
· Net sales increased by 10.6% to EUR 27.1 million (24.5)
· Net sales of Industrial Solutions Business Unit (IBU) increased by 24.0% to
EUR 4.9 (4.0)
· Net sales of Medical Business Unit (MBU) increased by 0.6% to EUR 10.9
million (10.8)
· Net sales of Security Business Unit (SBU) increased by 16.2% to EUR 11.3
million (9.7)
· Operating profit (EBITA) excluding non-recurring items (NRI) was EUR 4.2
million (2.2)
· Operating margin (EBITA-%) excluding NRI was 15.3% of net sales (9.0%)
· Operating profit (EBITA) was EUR 4.2 million (1.3)
· Operating margin (EBITA-%) was 15.3% of net sales (5.4%)
January-September 2024 highlights
· Net sales increased by 4.7% to EUR 75.9 million (72.5)
· Net sales of IBU increased by 24.5% to EUR 13.9 (11.1)
· Net sales of MBU decreased by -15.9% to EUR 29.7 million (35.3)
· Net sales of SBU increased by 24.1% to EUR 32.3 million (26.1)
· Operating profit (EBITA) excluding non-recurring items (NRI) was 9.7 million
(5.0)
· Operating margin (EBITA-%) excluding NRI was 12.8% of net sales (6.9%)
· Operating profit (EBITA) was EUR 9.7 million (4.2)
· Operating margin (EBITA-%) was 12.8% of net sales (5.7%)
UNAUDITED (Figures in parentheses refer to the corresponding period of the
previous year.)
President and CEO, Hannu Martola:
“The improved result in Q3 of 2024 was pleasing. Our result improved both year
-on-year and from Q2 and was in line with our targets. Thanks to security and
industrial sales, our overall net sales experienced double-digit growth,
although medical sales lagged behind expectations. Our position as the trusted
partner in X-ray imaging is stable in all segments, and our global long-term
growth drivers are in the right place.
Good demand in our industrial solutions continued, and the food industry market
also returned to a growth path. In addition to the food industry, demand was
also strong in industrial computed tomography (CT) imaging and the specialty
tire industry. We saw growing demand for our line scanner products in
particular. Our industrial sales grew above the market, and we expect growth to
continue in Q4, albeit clearly more moderately due to the excellent sales
outcome in the comparison period.
Medical sales grew slightly despite the continuing impacts of the healthcare
reform in China, globally stagnant investment, and price competition. Although
the direction improved, we expected growth against a modest comparison period.
In our view, despite the uncertainty, the sharp market decline has stopped, and
the Chinese market is likely to recover slowly. We expect year-on-year medical
sales to decline slightly in Q4.
Demand for security applications remained stable in the Western markets and,
thanks to our position, our sales grew above the market. Growth was boosted by
both CT and line scanner detector solutions for the aviation industry. We expect
the tail wind in the aviation industry to continue in the Western markets, and
investments to accelerate also in border control and critical infrastructure
security. We expect the growth of our security solution sales to continue from
Q3 to Q4 but remain at the level of the exceptionally strong comparison period.
We are pleased with the decrease in working capital, the excellent cash flow and
the improved result in Q3. Our result was in line with our medium-term
profitability target of 15 percent. The growth in net sales, improved
productivity, and sales mix enabled the good development. In our view, the
direction will remain unchanged, and our result will slightly improve in Q4.
The development of our business operations progressed in the growing Indian
market. We are establishing a service and production facility in the Greater
Delhi area. Our goal is to dispatch first deliveries from our new facility in H1
of 2025. The project is important from the perspectives of developing local
customer service and competitiveness, as well as risk management, as is the case
with strengthening production in Finland.
The importance of regional business in relation to global operations is
increasing, and we are renewing our operating model accordingly. The new
regional business units to be established will be at the heart of the reform. We
believe that this will strengthen our market and customer orientation as well as
our competitive position in the fast-moving world. The new planned leadership
model is intended to enter into force at the beginning of 2025.
Global growth in the medical market will continue to be modest, and the demand
constraints indirectly affecting our business due to the healthcare reform in
China will continue through the end of the year. We expect medical sales to
decline slightly in Q4. Our security and industrial sales will continue to grow,
but high year-on-year comparative figures will make security sales growth, in
particular, appear modest. In our view, our security and industrial sales will
grow in Q4. We expect our year-on-year total net sales to remain stable in Q4 of
2024 and Q1 of 2025.”
Key figures
(EUR 1,000) 7-9/2024 7-9/2023 1-9/2024 1-9/2023 1-12/2023
Net sales 27,103 24,507 75,901 72,479 103,794
Change in net 10.6% -10.2% 4.7% 3.0% 5.3%
sales, %
EBITA 4,157 2,207 9,726 5,034 9,656
excluding NRI
EBITA 15.3% 9.0% 12.8% 6.9% 9.3%
excluding
NRI, %
Non-recurring 0 -873 0 -873 -873
items (NRI)
EBITA 4,157 1,334 9,726 4,161 8,784
EBITA, % 15.3% 5.4% 12.8% 5.7% 8.5%
R&D costs 2,694 2,938 8,255 8,979 11,702
R&D costs, % 9.9% 12.0% 10.9% 12.4% 11.3%
of net sales
Cash flow 6,415 3,279 13,242 5,598 9,672
from
operating
activities
Net interest -20,797 -10,887 -20,797 -10,887 -12,665
-bearing debt
at end of
period
Investments 248 11,389 1,733 12,217 14,426
Return on 17.0% 6.9% 17.0% 6.9% 9.9%
investment
(ROI),
Gearing, % -27.1% -15.5% -27.1% -15.5% -17.4%
share, EUR
share
(diluted),
Number of 14,655,930 14,655,930 14,655,930 14,655,930 14,655,930
shares at the
of the period
Weighted 14,655,930 14,655,930 14,655,930 14,655,930 14,655,930
average
number of
shares
outstanding
Weighted 14,666,184 14,655,930 14,661,289 14,662,573 14,660,912
average
number of
shares
outstanding,
diluted
The development of net sales
Detection Technology’s total net sales increased by 10.6% (-10.2%) year-on-year,
totaling EUR 27.1 (24.5) million in Q3 of 2024. The double-digit growth was the
result of good demand continuing in particular in security and industrial
applications, but also the levelling of the downturn in the medical sector.
Despite the continued uncertainty in the industrial market, demand in X-ray
imaging applications continued to recover as expected in Europe in particular,
in addition to which the food industry also returned to the growth path. In
addition to the food industry, demand was strong in industrial CT imaging and
the tire industry. The net sales of the Industrial Solutions Business Unit (IBU)
grew by 24.0% (1.6%) year-on-year, totaling EUR 4.9 (4.0) million in Q3 of 2024.
Improved growth in the sales of the company’s legacy solutions was an important
growth driver. IBU generated a total of 18.2% (16.2%) of the company’s total net
sales.
The healthcare reform in China and the related anticorruption campaign
continued, which caused further delays in the purchasing processes of medical X
-ray imaging solutions. In addition, similar to Q2, stagnant investment and
price competition in the global market corroded demand in medical applications.
The company’s medical sales improved from Q2 and year-on-year, but, despite the
soft Q3 of 2023, net sales from Q3 of 2024 lagged behind expectations. The net
sales of the Medical Business Unit (MBU) increased by 0.6% (-27.0%) year-on
-year, totaling EUR 10.9 (10.8) million in Q3 of 2024. MBU generated a total of
40.2% (44.1%) of the company’s total net sales.
Growth in the demand for security applications remained stable in the Western
markets. Regarding sales per applications, the main growth driver was aviation,
but there is also increasing demand for X-ray imaging solutions in border
control and critical infrastructure security. The net sales of the Security
Business Unit (SBU) increased above market by 16.2% (13.7%) year-on-year,
totaling EUR 11.3 (9.7) million in Q3 of 2024. Growth was mainly generated by
aviation CT and line scanner applications. SBU generated a total of 41.7%
(39.6%) of the company’s total net sales.
The Asia-Pacific countries (APAC) accounted for the company’s largest
geographical market area in Q3 of 2024, with its 66.1% (70.4%) share of total
net sales. The share of Europe, Middle East and Africa (EMEA) was 26.5% (20.0%)
and Americas 7.4% (9.6%). Sales in the Americas were still decreasing due to
client structural reasons. A significant proportion of end products sold in the
American markets are manufactured elsewhere. The share of net sales accounted
for by Detection Technology’s five largest customers was 56.9% (53.4%).
The company’s total net sales grew by 4.7% (3.0%), totaling EUR 75.9 (72.5)
million in January–September 2024. IBU’s net sales grew by 24.5% (-2.6%),
totaling EUR 13.9 (11.1) million. MBU’s net sales decreased by -15.9% (-0.6%),
totaling EUR 29.7 (35.3) million. SBU’s net sales grew by 24.1% (11.2%),
totaling EUR 32.3 (26.1) million. IBU generated a total of 18.3% (15.4%) of the
company’s net sales, MBU a total of 39.1% (48.7%) and SBU a total of 42.6%
(36.0%).
APAC’s share of total net sales was 67.8% (68.7%), that of EMEA’s 26.3% (19.7%),
and that of the Americas’ 5.9% (11.6%) in January–September 2024. The company’s
five largest customers accounted for 52.1% (50.5%) of the company’s total net
sales.
Strategy implementation
During Q3 of 2024, Detection Technology commenced the establishment of a service
and production facility in India, where significant infrastructural investments
will be made in healthcare, transport and the manufacturing industry at the
national level. For example, more than 100 airports will be built in India over
the coming years. The objective of the establishment of the new facility is to
enhance customer experience in the growing Indian market by offering a local
service, shorter response and delivery times and cost-efficient local product
solutions.
Deliveries from the new facility are scheduled to start in the first half of
2025. In its new Indian facility, the company will first focus on the end
-assembly and final testing of X-ray detector solutions optimized for security
applications. The company’s goal is to also scale up production capabilities to
cover TFT (thin-film transistor) flat panel detector solutions, so that it can
offer local solutions to the diverse range of imaging needs in the industrial
and medical sectors.
The new service and production facility is located in an industrial hub
Cyberwalk Tech Park in the Delhi area with excellent connections to all corners
of India and the rest of the world. The Indian subsidiary fully owned by
Detection Technology is registered as DT Detection Technology India Private Ltd.
The manufacturing of EU Origin products at the company’s Oulu site has
progressed as planned and production capacity will be scaled up based on the
demand. The company will have the capability to manufacture in Finland 10
percent of its sold products by the end of the year. Production in Finland has
been expanded in order to offer a wider range of EU Origin products and to
minimize risks.
Events after the review period ended
Detection Technology announced on 29 October 2024, that it will change its
operating model and corresponding organization. The new sales and product
organization will consist of three regional business units: Asia–Pacific (APAC),
Europe, Middle East, India and Africa (EMEIA), and Americas. The Group level
functions, which include research and development (R&D), operations, financial
administration and IT, and HR, will remain the same. In addition, a member
responsible for business development will be appointed to the management group.
The planned new organization and reporting structure are intended to enter into
force as of 1 January 2025.
Business outlook
Detection Technology expects its year-on-year total net sales to remain stable
in Q4 of 2024 and Q1 of 2025.
Detection Technology refines its previous H2 of 2024 estimate of double-digit
growth in total net sales (published 6 August 2024) to growth in total net sales
for H2 of 2024.
Geopolitical situation, U.S.–China relations, global economy, the measures taken
in China to reform its healthcare, price competition especially in China, the
indirect impacts of the war in Ukraine, and events in the Middle East create
uncertainty.
Detection Technology aims to increase its sales by at least 10% per annum and to
achieve an operating margin (EBITA) of 15% in the medium term.
Financial statements review 2024
Detection Technology will publish its financial statements review for 2024 on
Thursday 6 February 2025.
Espoo, Finland 28 October 2024
Board of Directors, Detection Technology Plc
Further information
President and CEO Hannu Martola will be available for interviews and further
information on the release date at 9:00-11:00 (EET).
Hannu Martola, President and CEO
Nordea is the company’s Certified Advisor under the Nasdaq First North GM rules,
Detection Technology is a global provider of X-ray detector solutions and
services for medical, security, and industrial applications. The company’s
solutions range from sensor components to optimized detector subsystems with
ASICs, electronics, mechanics, software, and algorithms. It has sites in
Finland, China, France, India, and the US. The company’s shares are listed on
Nasdaq First North Growth Market Finland under the ticker symbol DETEC.
Circulation: Nasdaq Helsinki, main media, www.deetee.com
If you would rather not receive future communications from Detection Technology Oyj, please go to https://optout.ne.cision.com/en/2zx4yer31nz94vfJtEZ7VXqYLtpbf7eCP6DhPaz7EtqqLrHCtgMhjoozqLpN53RKgHsccxjbRRhzKf41jHLzba2MxfDqyGgXcpTmgtTUrRHdSq.
Detection Technology Oyj, A Grid, Otakaari 5A, Espoo, 02150 Finland
————————————————————
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
If you would rather not receive future communications from Detection Technology Oyj, please go to https://optout.ne.cision.com/en/2zx4yer31nz94vfJtEZ7VXqYLtpbf7eCP6DhPaz7EtqqLrHCtgMhjoozqLpN53RKgHsccxjbRRhzKf41jHLzba2MxfDqyGgXcpTmgtTUrRHdSq.
Detection Technology Oyj, A Grid, Otakaari 5A, Espoo, 02150 Finland
Report this content
Trending
- Elio Lannutti: M5S e Draghi grillino? Io c’ero, fin dalle origini!“Conoscere per deliberare” (Luigi Einaudi).
- Camera dei deputati: Alle 10 nella Sala della Regina – Io scrivo soltanto per fare politica. L’impegno civile di Leonardo Sciascia. Saluto del segretario di Presidenza Della Vedova.
- FAO Food Outlook: Global food commodity supplies remain generally ample, but risks are mounting [FAO news release]
- Ricerca, Rubano (FI): “Quasi 32 milioni alla Campania, valorizzato anche l’Ateneo del Sannio”
- TOR SAN LORENZO – IL “CAVALLO DI RITORNO” NON RIESCE. ARRESTATI DAI CARABINIERI DUE UOMINI MENTRE RESTITUISCONO ATTREZZATURE RUBATE IN CAMBIO DI DENARO
- COMUNICATO STAMPA VICARI – ARRESTATO UN 20ENNE E DENUNCIATO UN 50ENNE DAI CARABINIERI.doc
- Da S.I. Excelsior emerge una Basilicata produttiva
- Fagioli di Sarconi IGP, nasce il Consorzio di tutela
- Tagli indiscriminati nell’area protetta a Santa Marinella: denunciato il titolare di un’impresa boschiva
- Roma, Filini (FdI): Presentata interrogazione su emergenza storni, Gualtieri chiarisca